AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Control Bionics Ltd

0.066

+0.0011.54%

Volume:253.79K

Turnover:16.04K

Market Cap:35.84M

PE:-3.37

High:0.066

Open:0.064

Low:0.063

Close:0.065

52wk High:0.095

52wk Low:0.032

Shares:543.09M

Float Shares:114.48M

Volume Ratio:0.89

T/O Rate:0.22%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-122.92%

ROA:-48.20%

PB:5.68

PE(LYR):-3.37

Loading ...

Overview Company News Filings

Control Bionics Ltd-Neurostrip Ce Marked for Sale Across Europe

THOMSON REUTERS

Control Bionics - Signs Distribution Agreement with Tobii Dynavox Gmbh for Distribution of Neuronode in Germany

THOMSON REUTERS

Control Bionics Posts Full-Year Loss Attributable of A$7.3 Million

Control Bionics Ltd -Sees FY27 Revenue Growth of 50% over FY26

THOMSON REUTERS

Control Bionics - FY Loss Attributable to Owners A$7.3 Mln

THOMSON REUTERS

Control Bionics Ltd-Preliminary Final Report

THOMSON REUTERS

Control Bionics Ltd - Final US Market Access Prerequisite Cleared with First Revenues Targeted for September 2026

THOMSON REUTERS

Control Bionics Ltd - Medicare Billing Code Secured for Nextlevel Speech Devices

THOMSON REUTERS

Control Bionics Receives UK MHRA Registration for Neurostrip

Control Bionics - Receives UK Mhra Registration for Neurostrip

THOMSON REUTERS

An Insider Of Control Bionics Picks Up 183% More Stock

Simply Wall St.

Australia's Control Bionics Jumps After FDA Listing for NeuroStrip Device

Control Bionics Completes US FDA Registration, Device Listing for Neurostrip

Control Bionics Ltd-US FDA Registration and Device Listing for Neurostrip

THOMSON REUTERS

CBL & Associates Properties (CBL) Could Be 21% Overvalued After Russell Index Removals

Simply Wall St.

Control Bionics Ltd-security Purchase Plan Offer Document

THOMSON REUTERS

CBL & Associates Properties (CBL) Drops From Russell Value Indices, Does It Look Fully Valued?

Simply Wall St.

BRIEF-Control Bionics Says Trading Halt

Control Bionics - Trading Halt Requested Pending Material Capital Raising Announcement

THOMSON REUTERS

Control Bionics Ltd-Commercial Momentum, Execution and Market Access Update

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/CBL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CBL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","market":"AU","secType":"STK","nameCN":"Control Bionics Ltd","latestPrice":0.066,"timestamp":1791436320000,"preClose":0.065,"halted":0,"volume":253785,"delay":0,"changeRate":0.015384615384615398,"nameEN":"Control Bionics Ltd","floatShares":114482928,"shares":543088709,"eps":-0.0196,"marketStatus":"Closed","change":0.001,"latestTime":"10-08 16:12:00 AEDT","open":0.064,"high":0.066,"low":0.063,"amount":16043,"amplitude":0.046154,"askPrice":0.067,"askSize":31698,"bidPrice":0.063,"bidSize":92879,"shortable":3,"etf":0,"ttmEps":-0.0196,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.065,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":0.887153,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CBL.AU","preClose":0.062,"auctionPrice":0.062,"auctionVolume":128,"auction":3,"marketStatus":"盘后竞价","timestamp":1790834400537}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CBL.AU\",,,,,undefined,":{"symbol":"CBL.AU","floatShares":114482928,"roa":"-48.20%","roe":"-122.92%","lyrEps":-0.0196,"volumeRatio":0.887153,"shares":543088709,"dividePrice":0,"high":0.066,"amplitude":0.046154,"preClose":0.065,"low":0.063,"week52Low":0.032,"pbRate":"5.68","psRate":"7.52","week52High":0.095,"institutionHeld":0,"latestPrice":0.066,"committee":0.49111,"eps":-0.0196,"divideRate":0,"volume":253785,"delay":0,"ttmEps":-0.0196,"open":0.064,"prevYearClose":0.061,"prevWeekClose":0.061,"prevMonthClose":0.062,"prevQuarterClose":0.062,"fiveDayClose":0.062,"twentyDayClose":0.06,"sixtyDayClose":0.07,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CBL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-28","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787875200000,"name":null,"time":"","dateTimestamp":1787839200000,"actualEps":null},{"market":"AU","date":"2026-02-26","symbol":"CBL.AU","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1772024400000,"reportTimeType":"","actualEps":null},{"market":"AU","date":"2025-09-01","symbol":"CBL.AU","defaultRemindTime":1756684800000,"type":"split","dateTimestamp":1756648800000,"forFactor":982905,"toFactor":1000000,"ratio":0.9829049999999999},{"date":"2025-07-31","symbol":"CBL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753920000000,"name":null,"time":"","dateTimestamp":1753884000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CBL.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CBL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673776377","title":"Control Bionics Ltd-Neurostrip Ce Marked for Sale Across Europe","url":"https://stock-news.laohu8.com/highlight/detail?id=2673776377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673776377?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:11","pubTimestamp":1791151892,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261004:nTUE6DHFJZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669206051","title":"Control Bionics - Signs Distribution Agreement with Tobii Dynavox Gmbh for Distribution of Neuronode in Germany","url":"https://stock-news.laohu8.com/highlight/detail?id=2669206051","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669206051?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:18","pubTimestamp":1790115530,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E12Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662037000","title":"Control Bionics Posts Full-Year Loss Attributable of A$7.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037000","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037000?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:41","pubTimestamp":1787881292,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Posts Full-Year Loss Attributable Of A$7.3 MillionAug 28 (Reuters)-Control Bionics LtdCBL.AX:PRELIMINARY FINAL REPORTFY LOSS ATTRIBUTABLE TO OWNERS A$7.3 MILLIONFY REVENUE A$4.8 MILLIONNO DIVIDENDS PAID, RECOMMENDED OR DECLARED FOR FY2026Further company coverage:CBL.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260828:nTUE3C37W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031663","title":"Control Bionics Ltd -Sees FY27 Revenue Growth of 50% over FY26","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031663","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031663?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:20","pubTimestamp":1787872804,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nFWN44O1J8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031846","title":"Control Bionics - FY Loss Attributable to Owners A$7.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031846","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031846?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:02","pubTimestamp":1787871761,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE3C37W:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031819","title":"Control Bionics Ltd-Preliminary Final Report","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031819?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:02","pubTimestamp":1787871761,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nTUE3C37W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740892","title":"Control Bionics Ltd - Final US Market Access Prerequisite Cleared with First Revenues Targeted for September 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740892","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740892?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:00","pubTimestamp":1787781633,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N14D:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662740814","title":"Control Bionics Ltd - Medicare Billing Code Secured for Nextlevel Speech Devices","url":"https://stock-news.laohu8.com/highlight/detail?id=2662740814","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662740814?lang=en_us&edition=fundamental","pubTime":"2026-08-27 06:00","pubTimestamp":1787781633,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260826:nFWN44N14D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662207256","title":"Control Bionics Receives UK MHRA Registration for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2662207256","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662207256?lang=en_us&edition=fundamental","pubTime":"2026-08-25 09:34","pubTimestamp":1787621655,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Receives UK MHRA Registration For NeurostripAug 25 (Reuters)-Control Bionics LtdCBL.AX:RECEIVES UK MHRA REGISTRATION FOR NEUROSTRIPFurther company coverage:CBL.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260825:nFWN44L0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662204195","title":"Control Bionics - Receives UK Mhra Registration for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2662204195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662204195?lang=en_us&edition=fundamental","pubTime":"2026-08-25 07:50","pubTimestamp":1787615400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nFWN44L0UZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659664185","title":"An Insider Of Control Bionics Picks Up 183% More Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2659664185","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659664185?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:02","pubTimestamp":1786564925,"startTime":"0","endTime":"0","summary":"Investors who take an interest in Control Bionics Limited ( ASX:CBL ) should definitely note that insider Stephen Rix...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice2-main-header/1585186837163"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/an-insider-of-control-bionics-picks-up-183-more-stock","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-cbl/control-bionics-shares/news/an-insider-of-control-bionics-picks-up-183-more-stock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656583245","title":"Australia's Control Bionics Jumps After FDA Listing for NeuroStrip Device","url":"https://stock-news.laohu8.com/highlight/detail?id=2656583245","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656583245?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:43","pubTimestamp":1785804218,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Control Bionics jumps after FDA listing for NeuroStrip device** Shares of Australia's Control BionicsCBL.AXrise as much as 10.8% to A$0.072, posting their biggest intraday pct gain since June 5** Stock hits its highest level since July 16** Neurotechnology firm says its NeuroStrip surface EMG wearable platform has been registered and listed with the U.S. Food and Drug Administration  as a medical device** NeuroStrip offers insight into muscle activation and intent through bioelectric signals and spatial movements** CBL has also submitted applications for regulatory approval in additional key jurisdictions, including registration with the Therapeutic Goods Administration  in Australia, among others** Stock up nearly 15% this year, including the day's move","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL4N44101L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300902","title":"Control Bionics Completes US FDA Registration, Device Listing for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300902","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300902?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:41","pubTimestamp":1785796903,"startTime":"0","endTime":"0","summary":"Aug 4 (Reuters) - Control Bionics Ltd::*US FDA REGISTRATION AND DEVICE LISTING FOR NEUROSTRIP*Further company coverage: CBL.AX* ((Reuters.Briefs@thomsonreuters.com;))((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))Source Date/Time = 03-AUG-202622:27:59 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nRSD776kkg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656300528","title":"Control Bionics Ltd-US FDA Registration and Device Listing for Neurostrip","url":"https://stock-news.laohu8.com/highlight/detail?id=2656300528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656300528?lang=en_us&edition=fundamental","pubTime":"2026-08-04 06:26","pubTimestamp":1785796011,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nTUEBBMJYL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650945967","title":"CBL & Associates Properties (CBL) Could Be 21% Overvalued After Russell Index Removals","url":"https://stock-news.laohu8.com/highlight/detail?id=2650945967","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650945967?lang=en_us&edition=fundamental","pubTime":"2026-07-09 12:54","pubTimestamp":1783572845,"startTime":"0","endTime":"0","summary":"CBL & Associates Properties (CBL) has just been dropped from several Russell Value indices, a broad index reset that can affect how index funds treat the stock and may help explain recent shifts in its market profile.\nSee our latest analysis for CBL & Associates Properties.\nSet against the Russell Value index removals, CBL & Associates Properties has seen mixed short term sentiment. The 1 day share price return is down 3.08% and the 7 day share price return is down 6.15%. However, the 30 day...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-could-be-21-overvalued-after-r","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-could-be-21-overvalued-after-r","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","DCF","BK4080","CBL","BK4231","BK7007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648520323","title":"Control Bionics Ltd-security Purchase Plan Offer Document","url":"https://stock-news.laohu8.com/highlight/detail?id=2648520323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648520323?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:50","pubTimestamp":1782953403,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE6SRBSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648042542","title":"CBL & Associates Properties (CBL) Drops From Russell Value Indices, Does It Look Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2648042542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648042542?lang=en_us&edition=fundamental","pubTime":"2026-07-01 23:59","pubTimestamp":1782921564,"startTime":"0","endTime":"0","summary":"Index removals put CBL & Associates Properties in focus\nCBL & Associates Properties (CBL) has been removed from several Russell value indices, a mechanical shift that can prompt index-tracking funds to adjust positions and often brings the stock onto active investors' watchlists.\nSee our latest analysis for CBL & Associates Properties.\nDespite the index removals, CBL & Associates Properties has seen firm momentum recently, with a 7 day share price return of 5.99% and a 90 day share price...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551736-choice2-main-header/1585186602415"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-drops-from-russell-value-indic","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/real-estate/nyse-cbl/cbl-associates-properties/news/cbl-associates-properties-cbl-drops-from-russell-value-indic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CBL.AU","BK4231","BK7007","DCF","BK4080","CBL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645631168","title":"BRIEF-Control Bionics Says Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2645631168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645631168?lang=en_us&edition=fundamental","pubTime":"2026-06-24 09:36","pubTimestamp":1782264990,"startTime":"0","endTime":"0","summary":"BRIEF-Control Bionics Says Trading HaltJune 24 (Reuters) - Control Bionics Ltd CBL.AX:TRADING HALT REQUESTED PENDING MATERIAL CAPITAL RAISING ANNOUNCEMENTFurther company coverage: CBL.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42V0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645485064","title":"Control Bionics - Trading Halt Requested Pending Material Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2645485064","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645485064?lang=en_us&edition=fundamental","pubTime":"2026-06-24 08:11","pubTimestamp":1782259883,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nFWN42V0ZF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7007","CBL.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640875581","title":"Control Bionics Ltd-Commercial Momentum, Execution and Market Access Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2640875581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640875581?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:25","pubTimestamp":1780525549,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUE2MZP5P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CBL.AU","BK7007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}